Quantinno Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Quantinno Capital Management's RYTM Position: Q3 2026 in Review
Quantinno Capital Management increased its Rhythm Pharmaceuticals (RYTM) stake by 742% in Q3 2026, buying an estimated $3.04M and bringing the position to 32,325 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.
Quantinno Capital Management first reported a position in RYTM in Q2 2024 and has held it in 9 quarters since. 334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Quantinno Capital Management held 32,325 shares of Rhythm Pharmaceuticals worth $3.08M as of Q3 2026.
- Quantinno Capital Management bought 28,487 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $3.04M.
- Rhythm Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1834 holding.
- Quantinno Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.